Last updated: 2026-09-05 09:52:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
LivaNova PLC (LIVN) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $81,94, with a market capitalization of $4,47B and a P/E ratio of 23,94. Over the past 52 weeks, its price has ranged from $48,82 to $85,76. This page covers its latest market performance, valuation, price trends and company information.
$4,47B | |
$80,67 | |
$131,54 | |
$32,48 | |
$81,20 | |
266,71K | |
700,05K | |
23,94 | |
$85,76 | |
$48,82 | |
-- | |
-- |
LivaNova PLC (LIVN) last closed at $81,20 as of 2026-09-04 23:31:00, unchanged from the previous close of $81,20.
During the latest regular trading session, LIVN traded between $32,48 and $131,54, with a volume of 266,71K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, LivaNova PLC (LIVN) moved from $80,03 to $81,94, representing a gain of 2,38% ($1,91).
The stock traded between $77,28 and $83,52 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 579,18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 89,6%
LIVN is currently trading at $81,94, placing it 89,6% of the way from its 52-week low of $48,82 to its 52-week high of $85,76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 3300 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of LivaNova PLC (LIVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.